Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2058 (LINC02058) is a member of the lincRNA subclass of long non-coding RNAs, which are defined as RNA transcripts longer than 200 nucleotides that do not overlap with coding genes and generally lack protein-coding potential[5]. LINC02058, like other lincRNAs, is believed to be transcribed by RNA polymerase II and may have regulatory functions at the transcriptional, chromatin, or post-transcriptional level, though the specific function of LINC02058 has not been characterized in the available literature[5][3]. LincRNAs as a group are often involved in the regulation of gene expression, and some have roles in cancer and other diseases, but there is no current evidence supporting a role for LINC02058 as a therapeutic target, biomarker, or in a specific biological pathway[3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2058 (LINC02058).